Journal of Clinical Endocrinology & Metabolism, Vol 56, 946-952, Copyright © 1983 by Endocrine Society

ARTICLES

The molecular nature of circulating growth hormone in normal and acromegalic man: evidence for a principal and minor monomeric forms

G Baumann, JG MacCart and K Amburn

Human GH (hGH) extracted from pituitary glands consists of several molecular forms. Monomeric pituitary forms include the single chain 22,000-dalton polypeptide (22K; hGH-B), a 20,000-dalton variant with a 15-amino acid deletion (20K), 3 proteolytically cleaved 2-chain forms (hGH-C, -D, and -E), 2 deamidated forms, an acetylated form (fast hGH), and other, only partially characterized forms. It is not known which of these forms is secreted, nor what the precise nature of circulating hGH is. To answer these questions, we have extracted hGH from human plasma obtained by plasmapheresis from normal volunteers after L-dopa stimulation of hGH secretion and from acromegalic patients. We extracted and concentrated hGH by immunoadsorbent chromatography and examined its chemical nature by polyacrylamide gel electrophoresis under native and denaturing (sodium dodecyl sulfate and urea), nonreducing and reducing (dithiothreitol) conditions as well as by isoelectric focusing. In all cases, the predominant form of hGH present in plasma was 22K, which accounted for approximately 85% of all immunoreactive hGH. In addition, we found evidence for the presence of 20K as a minor form (approximately 7% of all hGH) and of one or more acidic forms (N-acetylated, deamidated, or cleaved hGH; 5-10% of all hGH). Exact identification of the acidic form(s) was not possible. However, the highly bioactive cleaved forms hGH-D and -E were judged to be undetectable (less than 5% of all hGH). We conclude that 1) several monomeric molecular forms of hGH circulate in normal and acromegalic man; 2) the pattern of circulating hGH forms reflects in part their relative prevalence in the pituitary gland; 3) proteolytically cleaved 2-chain hGH forms with enhanced bioactivity are not detectable in blood; and 4) monomeric hGH circulating in acromegaly is qualitatively indistinguishable from normal hGH.

This article has been cited by other articles:

				J. G. Langendonk, J. D. Veldhuis, J. Burggraaf, R. C. Schoemaker, A. F. Cohen, A. Edo Meinders, and H. Pijl Estimation of growth hormone secretion rate: impact of kinetic assumptions intrinsic to the analytical approach Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R225 - R232. [Abstract] [Full Text] [PDF]

				J. G. Langendonk, A. E. Meinders, J. Burggraaf, M. Frolich, C. A. M. Roelen, R. C. Schoemaker, A. F. Cohen, and H. Pijl Influence of obesity and body fat distribution on growth hormone kinetics in humans Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E824 - E829. [Abstract] [Full Text] [PDF]

				M. Ishikawa, S. Yokoya, K. Tachibana, Y. Hasegawa, T. Yasuda, E. Tokuhiro, Y. Hashimoto, and T. Tanaka Serum Levels of 20-Kilodalton Human Growth Hormone (GH) Are Parallel Those of 22-Kilodalton Human GH in Normal and Short Children J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 98 - 104. [Abstract] [Full Text]

				T. Tsushima, Y. Katoh, Y. Miyachi, K. Chihara, A. Teramoto, M. Irie, and Y. Hashimoto Serum Concentration of 20K Human Growth Hormone (20K hGH) Measured by a Specific Enzyme-Linked Immunosorbent Assay J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 317 - 322. [Abstract] [Full Text]

				P. U. Freda, K. D. Post, J. S. Powell, and S. L. Wardlaw Evaluation of Disease Status with Sensitive Measures of Growth Hormone Secretion in 60 Postoperative Patients with Acromegaly J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3808 - 3816. [Abstract] [Full Text]

				C. L. Boguszewski, G. Johannsson, B.-A. Bengtsson, A. Johansson, B. Carlsson, and L. M. S. Carlsson Circulating Non-22-Kilodalton Growth Hormone Isoforms in Acromegalic Men before and after Transsphenoidal Surgery J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1516 - 1521. [Abstract] [Full Text] [PDF]